About Taj Generics
Taj Generics is a Healthcare company. Generic pharmaceuticals manufacturing and distribution in India. Its Indian entity Taj Pharmaceuticals Limited reported revenue of ₹6.31 Cr. Taj Generics offers products and services including Generic Pharmaceuticals and Oncology Products. Its focus areas include Biopharmaceuticals, Biosimilars, Development and Pharmaceuticals.
Company details
Taj Generics is identified as a prominent entity in the generics pharmaceutical sector in India. A vast array of products, encompassing oncology items and generic medications, is marketed worldwide. The company maintains top positions in various markets and reaches consumers in more than 40 countries. Emphasis is placed on research, quality control, and regulatory affairs to ensure the efficacy and safety of offerings, with a commitment to infrastructure and services like dossiers and stability studies.
- SectorsHealthcare
- Email••••••••
- Social LinkedIn
- Legal Name Taj Pharmaceuticals Limited
- Date of Incorporation 05 Nov, 2004
- Jurisdiction Mumbai, Maharashtra, India
- Indian entity revenue₹6.31 Cr
FY 2024 · +31% YoY
- Indian entity net profit₹10.7 Lakh
FY 2024 · 2% margin
- Indian entity EBITDA₹1.30 Cr
FY 2024 · 21% margin
Associated legal entities of Taj Generics
Taj Generics operates through Taj Pharmaceuticals Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Taj Pharmaceuticals Limited CIN U24230MH2004PLC149424 | Active | 05 Nov 2004 | Mumbai, Maharashtra | ₹6.3 Cr | 3 | View details |
Products & Services of Taj Generics
Taj Generics offers a comprehensive portfolio of products and services, including Generic Pharmaceuticals and Oncology Products.
Generic drugs are manufactured to be equivalent to branded ones in quality and efficacy.
Various oncology medications are provided for cancer treatment purposes.
Board of directors of Taj Pharmaceuticals Limited (Taj Generics)
Taj Pharmaceuticals Limited is the primary company behind Taj Generics. The board of Taj Pharmaceuticals Limited currently have 3 directors; the longest-serving is Ranvir Kumar Bindeshwari Singh, appointed in 2004. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ranvir Kumar Bindeshwari Singh DIN 01725251 | Director | 05 Nov 2004 | 21 yrs 11 mo | Taj Pharmaceuticals Limited |
| Abhishek Ranvir Singh DIN 02706332 | Director | 10 Mar 2009 | 17 yrs 7 mo | Taj Pharmaceuticals Limited |
| Sudheer Singh DIN 06795666 | Director | 21 May 2013 | 13 yrs 5 mo | Taj Pharmaceuticals Limited |
Financials of Taj Generics
Figures of Taj Pharmaceuticals Limited, the primary company behind Taj Generics, for FY 2024. Revenue was ₹6.31 Cr (+31% year on year). Net profit was ₹10.7 Lakh (2% margin). EBITDA was ₹1.30 Cr (21% margin). Revenue has grown at a compounded annual rate of +23% over three years and +3% over five years.
- ₹6.31 CrRevenue · FY 2024 · +31% YoY
- ₹10.7 LakhNet profit · 2% margin
- ₹1.30 CrEBITDA · 21% margin
- ₹1.05 CrPaid-up capital
- +23%Revenue CAGR, 3 years
- +3%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Taj Pharmaceuticals Limited are on its company page.
Detailed financial statements for Taj Generics
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Taj Generics
Complete news archive for Taj Generics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Taj Generics
The primary company behind Taj Generics, Taj Pharmaceuticals Limited, reported revenue of ₹6.31 Cr for FY 2024, up 31% year on year.
Taj Generics is identified as a prominent entity in the generics pharmaceutical sector in India. A vast array of products, encompassing oncology items and generic medications, is marketed worldwide. The company maintains top positions in various markets and reaches consumers in more than 40 countries. Emphasis is placed on research, quality control, and regulatory affairs to ensure the efficacy and safety of offerings, with a commitment to infrastructure and services like dossiers and stability studies.
Taj Generics offers Generic Pharmaceuticals and Oncology Products.
Taj Generics operates through Taj Pharmaceuticals Limited.
The legal entities of Taj Generics currently have 3 directors, including Ranvir Kumar Bindeshwari Singh, Abhishek Ranvir Singh, Sudheer Singh.